Chris Bryant

Chris Bryant

Labour — Rhondda and Ogmore

Speaking in the House of Commons on 3 February 2025

Debate

AstraZeneca

Contribution

It is not entirely dependent on our AstraZeneca programme, and indeed, as I have already pointed out, the piece of work in which it was intending to invest—I hope I will get the science right—was changing the way in which it would create the nasal flu vaccine for children from an egg-based to a cell-based system. It has now decided not to do that, but to stick to the egg-based system. I think that if the chief scientific adviser or the chief medical officer has anything on which to update the House, he and/or she will do so.[Official Report, 12 February 2025; Vol. 762, c. 6WC.] (Correction)

More from Chris Bryant

Other recent Hansard contributions by the same speaker.

About Hansard

Hansard is the official verbatim record of proceedings in the UK Parliament. Every word spoken in the Commons and Lords is recorded and published — this page is a single contribution from that record.

For Chris Bryant's full parliamentary record including voting history, expenses and all other contributions, see the Chris Bryant report card.